The gut cytokine balance as a target of lead toxicity

Life Sciences

Volumn 64, Issue 24, 1999, Pages 2207-2214

  Goebel, Carsten ^a,c   Kirchhoff, Katja ^a   Wasmuth, Hermann ^a   Flohé, Stefanie ^a   Elliott, Robert B ^b   Kolb, Hubert ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Gut cytokine gene expression; IL 10; Lead chloride; Oral tolerance; TGF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; LEAD CHLORIDE; MESSENGER RNA; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; FEMALE; INTESTINE; LEAD POISONING; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; GENE EXPRESSION; IMMUNE TOLERANCE; INTESTINE, SMALL; LEAD; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; OVALBUMIN; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTE SUBSETS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0033532272     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00172-1     Document Type: Article

References (37)

1. J.H. Gainer, Environ. Health Perspect. 7 113-119 (1974).
2. G.L. Warner and D.A. Lawrence, Cell. Immunol. 101 425-439 (1986).
3. M.J. McCabe, J.A. Dias, and D.A. Lawrence, J. Biochem. Toxicol. 6 269-27 (1991).
4. M.D. Cohen, Z.J. Yang, and J.T. Zelikoff, Toxicol. Environ. Health 42 377-392 (1994).
5. Y. Heo, P.J. Parsons, and D.A. Lawrence, Toxieol. Appl. Pharmacol. 138 149-157 (1996).
6. R. Kuhn, D. Lohler, D. Rennick, K. Rajewsky, and W. Muller, Cell 75 263 (1993).
7. A.B. Kulkarni, C. Huh, D. Becker, A. Geiser, M. Lyght, K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward, and S. Karlsson, Proc. Natl. Acad. Sci. USA 90 770 (1993).
8. P. Garside, and A.M. Mowat, Crit. Rev. Immunol 17 119-137 (1997).
9. H.L. Weiner, Immunol. Today 18 335-343, (1997).
10. J. Kim and M. Ohsawa, Biol. Pharm. Bull. 18, 854-858 (1995).
11. F.W. Scott, H. E. Cloutier, R. Kleemann, U. Wörz-Pagenstert, P. Rowsell, H.W. Modler, and H. Kolb, Diabetes 46 589-598 (1997).
12. K. Bellmann, H. Kolb, S. Rastegar, P. Jee, and F.W. Scott, Diabetotogia 41 844-847 (1998).
13. H. Rothe, N. A. Jenkins, N. G. Copeland, and H. Kolb, J. Clin. Invest. 99 469-474 (1997).
14. C. Goebel, M. Kubicka-Muranyi, T. Tonn, J. Gonzales, and E. Gleichmann, Arch. Toxicol. 69 450-459 (1995).
15. W. Strober, B. Kelsall, I. Fuss, T. Marth, B. Ludviksson, R. Ehrhardt, and M. Neurath, Immunol. Today 18 61-64. (1997).
16. R.M. Martin and A.M. Lew, Immunol. Today 19 49. (1998).
17. J.J. Luan, R.C. Monteiro, C. Sautes, G. Fluteau, L. Eloy, W.H. Fridman, J.-F. Bach, and H.-J. Garchon, J. Immunol., 157 4707-4716 (1996).
18. Z. Zhang and J.G. Michael, J. Immunol 144 4163-4165 (1990).
19. M. Marinaro, P.N. Boyaka, F.D. Finkelman, H. Kiyono, R.J. Jackson, E. Jirillo, and J.R. McGhee, J. Exp. Med 185 415-427 (1997).
20. S. Strobel and A.M. Mowat, Immunol. Today 19 173-181 (1998).
21. V. Galliaerde, C. Desvignes, E. Peyron, and D. Kaiserlian, Eur. J. Immunol. 25 1385-1390 (1995).
22. H.M. Harper, L. Cochrane, and N.A. Williams, Immunology 89 449-456 (1996).
23. M.J. McCabe and D.A. Lawrence, Toxicol. Appl. Pharmacol 111 13-23 (1991).
24. Y. Heo, W.T. Lee, and D.A. Lawrence, Cell. Immunol 179 185-195.(1997).
25. Y. Heo, W.T. Lee, and D.A. Lawrence, Toxicol. Sci. 43, 172-185 (1998).
26. K.M. Gillespie, A. Saoudi, J. Kuhn; C.J. Whittle, P. Druet, B. Bellon, and P.W. Mathieson, Eur. J. Immunol. 26 2388-2392 (1996).
27. T.R. Mosmann and R.L. Coffman, Annu. Rev. Immunol. 7 145-173 (1989).
28. R.A. Seder, and W.E. Paul, Annu. Rev. Immunol 12 635-673 (1994).
29. T. Marth, W. Strober, R.A. Seder, and B.L. Kelsall, Eur. J. Immunol. 27 1213-1220(1997).
30. A. Rabinovitch, Diabetes 43 613-621 (1994).
31. J. Radons, V. Burkart, and H. Kolb, Diabetes 46 379-385 (1997).
32. M. Kjerrulf, D. Grdic, M. Kopf, and N. Lycke, Scand. J. Immunol. 47 401-407 (1998).
33. T. Krakauer, Cell. Immunol. 172 224-228 (1996).
34. J. Saltis, and A. Bobik, Clin. Exp. Pharmacol. Physiol. 23 573-575 (1996).
35. K. Murakami, G. Feng, and S.G. Chen, J. Pharmacol. Exp. Ther. 264 757-761 (1993).
36. S. Matsuyama, U. Namgung, and A. Routtenberg, Brain Res. 763 127-130 (1997).
37. M.J. Rapoport, A.H. Lazarus, A. Jaramllo, E. Speck; and T.L. Delovitch, J. Exp. Med. 177 1221-1226 (1993).